Takeda Pharmaceutical (TAK) EBT Growth (3y) (2020 - 2026)
Takeda Pharmaceutical (TAK) EBT Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 53.36% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 2.84% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 2.93% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 63.73% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -6.95% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -76.13% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 152.43% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 100.16% |
| 10 | Takeda Pharmaceutical | 171,987.39 | -6.60 Bn | 4.39 Bn | -31.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.71% |
| Dec 31, 2025 | 12.52% |
| Sep 30, 2025 | 135.69% |
| Jun 30, 2025 | 19.35% |
| Mar 31, 2025 | 6.40% |
| Dec 31, 2024 | 17.39% |
| Sep 30, 2024 | 121.24% |
| Jun 30, 2024 | -24.47% |
| Mar 31, 2024 | -31.22% |
| Dec 31, 2023 | 10.56% |
| Sep 30, 2023 | 262.08% |
| Jun 30, 2023 | -6.65% |
| Mar 31, 2023 | -20.35% |
| Sep 30, 2022 | 33.56% |
| Jun 30, 2022 | 135.55% |
| Mar 31, 2022 | -5.20% |
| Dec 31, 2021 | 14.60% |
| Sep 30, 2021 | 97,494.74% |
| Jun 30, 2021 | 133,133.09% |
| Mar 31, 2021 | 57.35% |